Marinus Days Sales Outstanding from 2010 to 2024
| MRNS Stock | USD 1.30 0.01 0.78% |
Days Sales Outstanding | First Reported 2010-12-31 | Previous Quarter 44.74603892 | Current Value 42.51 | Quarterly Volatility 131.4697398 |
Check Marinus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Marinus main balance sheet or income statement drivers, such as Depreciation And Amortization of 523.5 K, Interest Expense of 17.7 M or Selling General Administrative of 63.5 M, as well as many exotic indicators such as Price To Sales Ratio of 17.91, Dividend Yield of 0.0 or PTB Ratio of 36.59. Marinus financial statements analysis is a perfect complement when working with Marinus Pharmaceuticals Valuation or Volatility modules.
Marinus | Days Sales Outstanding |
Latest Marinus Pharmaceuticals' Days Sales Outstanding Growth Pattern
Below is the plot of the Days Sales Outstanding of Marinus Pharmaceuticals over the last few years. It is Marinus Pharmaceuticals' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Marinus Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Days Sales Outstanding | 10 Years Trend |
|
Days Sales Outstanding |
| Timeline |
Marinus Days Sales Outstanding Regression Statistics
| Arithmetic Mean | 273.38 | |
| Geometric Mean | 218.72 | |
| Coefficient Of Variation | 48.09 | |
| Mean Deviation | 111.94 | |
| Median | 349.70 | |
| Standard Deviation | 131.47 | |
| Sample Variance | 17,284 | |
| Range | 307 | |
| R-Value | (0.77) | |
| Mean Square Error | 7,468 | |
| R-Squared | 0.60 | |
| Significance | 0.0007 | |
| Slope | (22.75) | |
| Total Sum of Squares | 241,980 |
Marinus Days Sales Outstanding History
About Marinus Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Marinus Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Marinus Pharmaceuticals investors use historical funamental indicators, such as Marinus Pharmaceuticals's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Marinus Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Marinus Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Marinus Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Marinus Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Marinus Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Sales Outstanding | 44.75 | 42.51 |
Pair Trading with Marinus Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Marinus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marinus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Marinus Stock
| 0.78 | ACB | Aurora Cannabis Financial Report 12th of June 2024 | PairCorr |
| 0.74 | HCM | HUTCHMED DRC Earnings Call This Week | PairCorr |
| 0.68 | CGC | Canopy Growth Corp Earnings Call This Week | PairCorr |
| 0.53 | MRK | Merck Company Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Marinus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Marinus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Marinus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Marinus Pharmaceuticals to buy it.
The correlation of Marinus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Marinus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Marinus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Marinus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Marinus Pharmaceuticals Correlation against competitors. For more information on how to buy Marinus Stock please use our How to Invest in Marinus Pharmaceuticals guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Marinus Stock analysis
When running Marinus Pharmaceuticals' price analysis, check to measure Marinus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marinus Pharmaceuticals is operating at the current time. Most of Marinus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Marinus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marinus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Marinus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Marinus Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marinus Pharmaceuticals. If investors know Marinus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marinus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.64) | Revenue Per Share 0.514 | Quarterly Revenue Growth (0.26) | Return On Assets (0.46) | Return On Equity (4.23) |
The market value of Marinus Pharmaceuticals is measured differently than its book value, which is the value of Marinus that is recorded on the company's balance sheet. Investors also form their own opinion of Marinus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Marinus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marinus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Marinus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marinus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marinus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marinus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.